Soluble guanylyl cyclase activation promotes angiogenesis

被引:71
作者
Pyriochou, Anastasia [1 ]
Beis, Dimitris
Koika, Vasiliki
Potytarchou, Christos
Papadimitriou, Evangelia
Zhou, Zongmin
Papapetropoulos, Andreas
机构
[1] Univ Patras, Lab Mol Pharmacol, Dept Pharm, Patras 26504, Greece
[2] Acad Athens, Fdn Biomed Res, Basic Res Ctr Cell Biol, Athens, Greece
[3] Univ Athens, Sch Med, GP Livanos & M Simou Labs, Evangelismos Hosp,Dep Crit Care & Pulm Serv, GR-11527 Athens, Greece
关键词
D O I
10.1124/jpet.106.108878
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Soluble guanylyl cyclase (sGC) is a cGMP-generating enzyme carrying a heme prosthetic group that functions as a nitric oxide (NO) sensor. sGC is present in most cells types, including the vascular endothelium, where its biological functions remain largely unexplored. Herein, we have investigated the role of sGC in angiogenesis and angiogenesis-related properties of endothelial cells (EC). Initially, we determined that sGC was present and enzymatically active in the chicken chorioallantoic membrane (CAM) during the days of maximal angiogenesis. In the CAM, inhibition of endogenous sGC inhibited neovascularization, whereas activation promoted neovessel formation. Using zebrafish as a model for vascular development, we did not detect any effect on vasculogenesis upon sGC blockade, but we did observe an abnormal angiogenic response involving the cranial and intersegmental vessels, as well as the posterior cardinal vein. In vitro, pharmacological activation of sGC or adenovirus-mediated sGC gene transfer promoted EC proliferation and migration, whereas sGC inhibition blocked tube-like network formation. In addition, sGC inhibition blocked the migratory response to vascular EC growth factor. Cells infected with sGC-expressing adenoviruses exhibited increased extracellular signal-regulated kinase 1/2 and p38 MAPK activation that was sensitive to sGC inhibition by 1H-[1,2,4] oxadiazolo[4,3-a] quinoxalin-1-one, suggesting that these mitogen-activated protein kinases are downstream effectors of sGC in EC. A functional role for p38 in cGMP-stimulated migration was demonstrated using SB203580 [4-(4-fluorophenyl)-2-(4methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole]; pharmacological inhibition of p38 attenuated BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl]-pyrimidin-4- ylamine] and sGC overexpression-induced EC mobilization. We conclude that sGC activation promotes the expression of angiogenesis-related properties by EC and that sGC might represent a novel target to modulate neovessel formation.
引用
收藏
页码:663 / 671
页数:9
相关论文
共 38 条
[1]   Cell adhesion and angiogenesis [J].
Bischoff, J .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (03) :373-376
[2]   Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [J].
Carmeliet, P ;
Ferreira, V ;
Breier, G ;
Pollefeyt, S ;
Kieckens, L ;
Gertsenstein, M ;
Fahrig, M ;
Vandenhoeck, A ;
Harpal, K ;
Eberhardt, C ;
Declercq, C ;
Pawling, J ;
Moons, L ;
Collen, D ;
Risau, W ;
Nagy, A .
NATURE, 1996, 380 (6573) :435-439
[3]   Molecular mechanisms of blood vessel growth [J].
Conway, EM ;
Collen, D ;
Carmeliet, P .
CARDIOVASCULAR RESEARCH, 2001, 49 (03) :507-521
[4]   Novel effects of nitric oxide [J].
Davis, KL ;
Martin, E ;
Turko, IV ;
Murad, F .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2001, 41 :203-236
[5]   The biology of VEGF and its receptors [J].
Ferrara, N ;
Gerber, HP ;
LeCouter, J .
NATURE MEDICINE, 2003, 9 (06) :669-676
[6]  
FOLKMAN J, 1992, J BIOL CHEM, V267, P10931
[7]   Regulation of nitric oxide-sensitive guanylyl cyclase [J].
Friebe, A ;
Koesling, D .
CIRCULATION RESEARCH, 2003, 93 (02) :96-105
[8]  
GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184
[9]   Soluble guanylate cyclase: the forgotten sibling [J].
Hobbs, AJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1997, 18 (12) :484-491
[10]   The early ontogeny of neuronal nitric oxide synthase systems in the zebrafish [J].
Holmqvist, B ;
Ellingsen, B ;
Forsell, J ;
Zhdanova, I ;
Alm, P .
JOURNAL OF EXPERIMENTAL BIOLOGY, 2004, 207 (06) :923-935